Nichols Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$750K Hold
11,484
1.47% 17
2016
Q3
$812K Buy
11,484
+469
+4% +$34.2K 1.52% 15
2016
Q2
$814K Hold
11,015
1.65% 15
2016
Q1
$715K Hold
11,015
0.16% 62
2015
Q4
$849K Hold
11,015
0.18% 61
2015
Q3
$907K Hold
11,015
0.2% 59
2015
Q2
$971K Hold
11,015
0.17% 64
2015
Q1
$973K Hold
11,015
0.17% 67
2014
Q4
$915K Hold
11,015
0.18% 68
2014
Q3
$929K Hold
11,015
0.19% 67
2014
Q2
$893K Hold
11,015
0.18% 65
2014
Q1
$839K Hold
11,015
0.19% 70
2013
Q4
$793K Sell
11,015
-139
-1% -$9.66K 0.17% 73
2013
Q3
$767K Hold
11,154
0.21% 72
2013
Q2
$707K Buy
+11,154
New +$726K 0.21% 68

Other funds holding NVS

Nichols Asset Management's NVS Position: Q4 2016 in Review

Nichols Asset Management held its Novartis (NVS) position steady in Q4 2016 at 11,484 shares worth $750K. The position accounts for 1.47% of the portfolio, ranked #17.

Nichols Asset Management first reported a position in NVS in Q2 2013 and has held it in 15 quarters since. The position peaked at $973K in Q1 2015. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

  • Nichols Asset Management held 11,484 shares of Novartis worth $750K as of Q4 2016.
  • Nichols Asset Management left its Novartis share count unchanged in Q4 2016.
  • Novartis made up 1.47% of Nichols Asset Management's portfolio in Q4 2016, its #17 holding.
  • Nichols Asset Management first reported a position in Novartis in Q2 2013 and has held it in 15 quarters since.
  • Nichols Asset Management's Novartis position peaked at $973K in Q1 2015.
  • 904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Nichols Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.